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Abstract
Historically, less attention has been paid to paternal effects on early embryogenesis than maternal
effects. However, it is now apparent that certain male factor infertility phenotypes are associated
with increased DNA fragmentation and/or chromosome aneuploidies that may compromise early
embryonic development. In addition, there is a growing body of evidence that the fertilizing sperm
has more function than just carrying an intact, haploid genome. The paternally inherited
centrosome is essential for normal fertilization, and the success of higher order chromatin
packaging may impact embryogenesis. Epigenetic modifications of sperm chromatin may contribute
to the reprogramming of the genome, and sperm delivered mRNA has also been hythesized to be
necessary for embryogenesis. There is less information about the epigenetic factors affecting
embryogenesis than genetic factors, but the epigenetics of gamete and early embryogenesis is a
rapidly advancing field.
Background
The contributions of sperm to embryogenesis are more
than just providing a haploid genome. In addition to
genetic material, sperm factors are involved in many
events, such as syngamy, cleavage and epigenetic regula-
tion. There is a growing body of evidence that besides
genetic abnormalities, epigenetic abnormalities may be
major contributors to idiopathic male infertility and may
affect IVF outcome [1]. Male factor infertility is responsi-
ble for approximately 50% of in vitro fertilization (IVF)
cases and the vast majority of male factor infertility is clas-
sified as idiopathic. Therefore, it is important to consider
the potential effects of genetic and epigenetic abnormali-
ties on not only male infertility, but also on the outcome
of IVF.
ICSI has become a widely used technique to treat many
types of male infertility associated with diminished sperm
quality. Due to its extensive application there is a growing
concern about propagating either genetic or epigenetic
disorders. Two such examples are transmission of Y chro-
mosome deletions [2] and a possible elevated incidence
of imprinting disorders such as Angelman syndrome or
Beckwith-Wiedemann syndrome [3-5]. Here we review
the origin of male factors (Figure 1.) that affect the fertili-
zation event and early embryogenesis as well as mecha-
nisms by which these factors have an effect.
Paternal age
In Western countries, paternal age has increased over the
last several decades, with a large number of men fathering
children after the age of 50 [6]. Maternal age is an obvious
contributor to poor fecundity [7], but little is known
about the effect of paternal age. The effect of paternal age
on embryogenesis has been measured by investigating the
correlation between paternal age and embryo quality,
miscarriage rate or pregnancy rate in the general popula-
tion or in infertile patients. Evaluation of the impact of
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paternal age on fertility is challenging because older men
usually have an older partner, and the exclusion of these
couples makes it difficult to reach the proper sample size
for evaluation.
An earlier review of the effects of male age on semen qual-
ity found that semen volume, sperm morphology, and
sperm motility are decreased in men with advanced age
but no significant reduction in sperm concentration has
been noted [6]. These finding were later confirmed by Ng
et al. [8]. Eskenazi et al. studied a recruited healthy popu-
lation and found a significant age-related decrease in
semen quality. The largest age related effect was seen on
sperm motility and semen volume, while sperm count
was less affected [9]. Age-dependent changes in the testis
have been well documented. The number of Leydig cells
decrease with age, which leads to a decreased testosterone
level and the number of type A spermatogonia is also
reduced, and an age-related decrease in testicular tubular
lumen has been observed [10].
In IVF cases using donor oocytes from women <35 years
of age, the effect of maternal age can be excluded. A recent
study showed a significant decrease in the number of day
5 blastocysts in men >55 years old, but no difference was
observed in earlier developmental stages. A higher preg-
nancy loss and decreased live birth rate has also been
reported in men over the age of 50 [11]. Watanabe et al.
showed a 10% decrease in fertilization rate with semen
from men ≥ 39 years old compared to those who were
under 39. When the number of donated oocytes was 5 or
less, the clinical pregnancy rate was also reduced in cou-
ples with an older male partner [12]. However Gallardo et
al. and Paulson et al. saw no effect on pregnancy rates
[13,14].
The effect of paternal age on pregnancy outcome follow-
ing natural conception has been investigated in popula-
tion-based studies. In a prospective study, a significantly
higher spontaneous abortion rate was found in women
with male partners older than 45 years compared to those
whose partners were less than 25 years of age [15]. Klein-
haus et al. reported that partners of women 40 years or
older had an almost three-fold increase in spontaneous
abortion compared to those women with a partners 25
years old or younger [16].
Analyzing IVF cycles, a negative effect of advancing pater-
nal age on pregnancy and live birth rate after IVF and gam-
ete intrafallopian transfer has been reported [17]. In
another study in which IVF data from 1,938 couples were
retrospectively analyzed, an increased risk of conception
failure was noted in men over 40 years old [18]. However,
several reports indicate that paternal age does not affect
pregnancy outcome in ICSI cycles [19-21].
The possible reason behind these results could be increas-
ing sperm DNA fragmentation with age [22], possibly due
to a decrease in apoptotic activity during spermatogenesis
[23]. It has been hypothesized that sperm aneuploidy is
also a contributor to pregnancy loss among partners of
aging men [24], however an exact relationship between
aging and sperm aneuploidy has not been established. A
significantly higher frequency of chromosome aberrations
was found in men older than 59 compared with men
younger than 40 [25], but it has not been confirmed by
another group. They found no age-related change in the
incidence of sperm aneuploidy [22].
The current body of data suggests advancing paternal age
is associated with decreasing sperm characteristics that
may reduce the chance for fathering, particularly in men
over 50 years of age [6,9]. While still not definitively dem-
onstrated, IVF outcome may be moderately affected by
paternal age [26].
The origin of genetic and epigenetic abnormalities during  spermatogenesis Figure 1
The origin of genetic and epigenetic abnormalities during 
spermatogenesis. The DNA methylation pattern is estab-
lished during germ cell development. Spermatocytogenesis 
can also give rise to chromosome nondisjunction during its 
meiosis I and II along with double strand breaks, abnormal 
histone modification and alteration in the expression of 
mRNA and other non-coding RNAs. Abnormal protamine 
replacement or centrosome formation can take place at the 
final stage of spermatogenesis where round spermatids dif-
ferentiate to mature spermatozoa. DNA fragmentation is 
mainly the result of apoptosis following double strand breaks 
or abnormal protamination during spermiogenesis.Journal of Experimental & Clinical Assisted Reproduction 2008, 5:2 http://www.jexpclinassistreprod.com/content/5/1/2
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The source of sperm
The effect of sperm source on embryogenesis has been
investigated in a limited number of retrospective studies.
An early study by Nagy et al. concluded that using fresh
and frozen-thawed epididymal and testicular spermato-
zoa from obstructive azoospermic patients gave results
that were comparable to those obtained from ejaculated
spermatozoa following ICSI [27]. Similar results using
ejaculated sperm compare to epididymal or testicular
sperm from patients with obstructive azoospermia has
also been reported, however lower fertilization and preg-
nancy rates were observed using testicular sperm patients
from non-obstuctive azoospermia [28]. Another group
also reported higher fertilization rate using ejaculated
sperm compared to testicular sperm from non-obstructive
azoospermic men, but further differences were not
observed in the developmental data [29].
Some data indicate that patients with obstructive
azoospermia can achieve higher fertilization, implanta-
tion and birth rate compare to those who have non-
obstructive azoospermia [21,30]. Similarly, higher fertili-
zation and implantation rates have been observed com-
paring obstructive to non-obstructive azoospermic
patients, but no difference was found in the pregnancy
rate [31]. Pasqualotto et al. find similar fertilization rate
between obstructive and non-obstructive azoospermic
patients but significantly reduced pregnancy and elevated
abortion rates [32]. There are indications that non-
obstructive azoospermic men have higher frequency of
aneuploid sperm [33-35], which can lead to miscarriage
[36].
Studies investigating the effect of sperm recovery sites in
obstructive azoospermic men found contradictory results.
No difference was observed in fertilization, pregnancy
rates [28] or birth rate when epididymal or testicular
sperm were used [21]. Another study reported a higher
implantation rate using testicular sperm over epididymal
sperm, however the pregnancy rate was not significantly
higher [37]. Buffat et al. also found a significantly higher
miscarriage rate using testicular spermatozoa than epidi-
dymal spermatozoa and concluded that this is probably
due to the affect of immaturity of testicular spermatozoa
on embryogenesis [38]. Regardless of the etiology of
azoospermia, similar pregnancy rate was reported using
testicular or epididymal sperm, but lower miscarriage rate
has been observed following ICSI using sperm retrieved
from the epididymis [39]. These studies suggest that the
fertilization and pregnancy rate is not compromised using
testicular biopsy-derived sperm from obstructive
azoospermic patients compared to using ejaculated
sperm.
Genetic factors
DNA fragmentation
DNA fragmentation has been associated with altered
reproductive outcome, although the rate of the correlation
varies between studies using different methods to detect
DNA damage [40]. DNA fragmentation is characterized by
single and double strand breaks, which are the result of
three main sources: abortive apoptosis, oxidative stress,
and general abnormalities in the process of recombina-
tion and protamination [40,41].
The key indicator of apoptosis is DNA strand breaks,
which, however, could also be unrelated to apoptosis,
since they are the result of normal processes as well, such
as chromatin remodeling or protamine replacement dur-
ing spermatogenesis [42]. Oxidative stress is the result of
the production of reactive oxidative species (ROS) and
insufficient antioxidant activity. Antioxidants along with
the highly compact structure of sperm chromatin are the
only defense mechanisms against free radicals [40,43].
Spermatozoa are highly vulnerable to oxidative stress,
since they are transcriptionally inactive and have only a
small amount of cytoplasm, which lacks both antioxi-
dants and a DNA-repair system [44]. Improper compac-
tion due to an altered protamine ratio has been shown to
result in significantly higher DNA damage, which con-
firms a strong correlation between protamination and
DNA integrity [45].
Several methods have been used to detect DNA fragmen-
tation such as sperm chromatin structure assay (SCSA),
terminal deoxynucleotidyl transferase-mediated dUDP
nick-end labeling (TUNEL) and single cell electrophoresis
(Comet) assay [40,42,46,47].
High DNA fragmentation is associated with diminished
sperm count, motility, and morphology [22,48,49].
Decreased fertilization and implantation rates associated
with increased DNA fragmentation have been reported
[49]. A negative correlation was observed between the
extent of DNA damage and developmental rate to the
blastocyst stage after IVF or ICSI [47,50]. An increased
incidence of sperm DNA fragmentation has also been
associated with higher spontaneous abortion rate [51] or
unexplained recurrent pregnancy loss [52].
Different DNA damage test provided different results in
relation to embryo development and pregnancy loss
between ICSI and IVF cases. DNA fragmentation detected
by TUNEL assay has been associated pregnancy loss in
ICSI cases while this relationship has not been established
in IVF cases [53]. Also in ICSI cases embryo cleavage was
negatively correlated to DNA fragmentation measured by
Comet assay [54]. SCSA test might be less sensitive detect-
ing differences between IVF and ICSI cases [55-57]. ToJournal of Experimental & Clinical Assisted Reproduction 2008, 5:2 http://www.jexpclinassistreprod.com/content/5/1/2
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define the exact relationship between these tests, their
results and IVF outcome more investigation is needed. It
seems the predictive value of DNA fragmentation for
unsuccessful IVF treatment cycle is stronger in ICSI cases
than in IVF cases.
Elevated DNA fragmentation in sperm from infertile
patients is a common pathology. Detection of DNA dam-
age can be advantageous especially for patients with idio-
pathic infertility, however the exact phenotype that can
benefit from it is still under investigation.
Sperm aneuploidy
Regardless of the chromosomes involved, most embry-
onic aneuploidies are of maternal origin, most commonly
as a result of a meiosis I error. However, a significant
paternal contribution to sex chromosome trisomies has
been shown [58,59].
Sperm morphology is normally not related to aneuploidy,
except in men especially with a high percentage of macro-
cephalic, multinucleated, and multiflagellate sperm or
severe oligoasthenoteratozoospermia show an increased
incidence of sperm aneuploidy [60-64]. Severe oligo-
zoospermia is also associated with higher aneuploidy rate
than normal fertile donors [35]. Nagvenkar et al. also
showed that patients with severe oligozoospermia have
higher frequency of XY and YY disomy than oligozoosper-
mic and normospermic men [65].
The importance of sperm aneuploidy is obvious given the
fact that spermatozoa with numerical chromosome
abnormalities are able to fertilize an oocyte, resulting ane-
uploid concepti [66]. In a case report it has been reported
that in case of two live-birth (47, XXY and 47, XYY) and
two spontaneously aborted (47, XX + 15 and 47, XX + 22)
pregnancies the father had elevated frequency of disomic
sperm for every chromosome involved in trisomic preg-
nancies [67]. An increased sperm aneuploidy rate has
been associated with lower implantation and pregnancy
rates and a higher incidence of miscarriage in ICSI cycles
[36,65,68,69].
The most commonly used technique for evaluating aneu-
ploidy in sperm samples is fluorescent in situ hybridiza-
tion (FISH), however there are techniques on the horizon,
such as array based comparative genomic hybridization
(aCGH), yielding a more complex assessment [70]. The
evaluation of homologous chromosome recombination
at prophase I of meiosis has recently gained attention.
Meiotic crossover is important for two reasons; first it con-
tributes to genetic variability; and second it provides a
physical connection for the proper segregation of chromo-
somes. Each bivalent must contain at least one recombi-
nation site. In the absence of a crossover, nondisjunction
can occur. Smaller chromosomes, which usually have
only one crossover such as chromosomes 21 or 22, have a
higher frequency of aneuploidy [71-73].
The number and position of recombination foci on indi-
vidual chromosomes in spermatocytes can be determined
by the immunostaining of elements in the synaptonemal
complex. Specifically, staining of MLH1, a marker of
crossover events, and CREST, which attached to the cen-
tromere, allows for both chromosomal enumeration and
the localization within the synaptonemal complexes.
Studies have demonstrated that infertile men either with
nonobstuctive azoospermia or obstructive azoospermia
show a lower frequency of recombination and a higher
number of cells with at least one bivalent without crosso-
ver than fertile controls. An increased number of gaps and
splits in the synaptonemal complexes are also observed in
infertile patients [74,75]. Lower rates of recombination
between chromosomes are associated with a higher risk of
producing disomic sperm [76].
These studies suggest that more care has to be taken with
those patients who have severe oligoastenoteratozoosper-
mia, non-obstructive azoospermia or unexplained recur-
rent pregnancy lost. The aneuploidy screening is highly
recommended for patients with these etiologies. Aneu-
ploidy screening an expensive and a very time consuming
process required about 10 hours of technician time. Using
automated analysis system might provide a solution since
it could reduce time by one third although it is still costly
[77]. If elevated frequency of aneuploidy confirmed, these
patients must be counseled for the elevated risk of miscar-
riage or conceiving aneuploid offspring.
Epigenetic factors
Centrosome functions
In most mammals, including humans the centrosome is
inherited from the fertilizing sperm. During spermatogen-
esis, centrosome reduction takes place resulting a single
centriole and reduced amount of pericentriolar material
in spermatids. In order to avoid abnormal fertilization the
maternal centrosome is fully degradeted, however pro-
teins that are essential for normal centrosome function,
such as γ-tubulin, during embryogenesis are maintained
in the oocyte [78-80]. After fusion of the gametes, the aster
forms from the sperm centrosome synchronously with
sperm head decondensation and the arising microtubule
organizing center (MTOC) promotes the proper position-
ing of the male and female pronuclei. The paternal centro-
some then duplicates during the first cell cycle to ensure
cleavage later on [78,81,82].
The transfer of a normally formed centriole to the oocyte
by the spermatozoa is essential for proper fertilization.
Malformation of the centrosome is associated with detri-Journal of Experimental & Clinical Assisted Reproduction 2008, 5:2 http://www.jexpclinassistreprod.com/content/5/1/2
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mental phenomenon at fertilization such as abnormal
sperm aster formation which leads to the failure or lack of
syngamy resulting in cleavage arrest [83]. Improper cen-
trosome function may also lead to numerical chromo-
somal abnormalities causing aneuploidy or mosaicism in
the embryo [84,85].
Centrosomes were usually assessed by transmission elec-
tron microscopy, however the technology is difficult,
laborious to carry out and provides information only
about the morphology of the centrosome [86] whereas
normal morphology does not always indicate proper
functionality. Microinjection of bovine, rabbit oocytes
with human sperm allow the immunohistochemical
study of aster formation [87-89]. This functional assay is
proven be a useful tool in studying abnormal centrosome
function in some cases, [83,89] although the wide-range
clinical application is unlikely due to the complexity of
the method.
Chromatin packaging
In human sperm, two protamines are expressed pro-
tamine 1 (P1) and protamine 2 (P2). Protamines replace
nuclear histones (H2A, H2B, H3 and H4) in a stepwise
manner, resulting in highly condensed and transcription-
ally silent chromatin during sperm maturation. In round
spermatids the chromatin structure is similar to that
observed in somatic cells. During spermiogenesis nuclear
histones become hyperacetylated and shortly there after
disassembly and replacement by testis-specific histone
variants followed by transition proteins (TP1 and TP2)
occurs. At the final stage of spermiogenesis, removal of
transition proteins takes place followed by protamine
replacement. In a mature human spermatozoon, 85% of
histones are replaced by protamines [43,90,91].
In humans, P1 and P2 are expressed in nearly equal quan-
tities, with the P1/P2 ratio close to 1, alteration of the pro-
tamine ratio in either direction is associated with
diminished sperm parameters. While altered protanime
ratio has never been observed in fertile men [91,92].
Abnormal P1/P2 ratio is associated with low sperm count,
reduced motility, abnormal head morphology, higher fre-
quency of DNA fragmentation and lower sperm penetra-
tion assay score [48,93]. Reduced fertilization rate has
also been observed in these patients following IVF cycles,
but ICSI results in normal rates. Altered P1/P2 ratio is
likely incompatible with the early events of the fertiliza-
tion process such as capacitation, acrosome reaction,
membrane fusion or penetration, but this can be over-
come using ICSI. Protamine deficiency evaluated by
chronomycin A3 (CMA3) may also correlate to fertiliza-
tion failure following ICSI because of premature sperm
chromosomal condensation (PCC) [94]. Decreased clini-
cal-pregnancy rates have been shown following fertiliza-
tion with sperm having reduced P1/P2 ratio [95].
Aberrant P1/P2 ratios can be the result of either P1 or P2
deregulation, however the majority of cases show P2
deregulation [93]. Normal sperm function requires a high
order of chromatin packaging. The protective function of
the tight protamine packaging against endogenous and
exogenous agents such as nucleases, free radicals or muta-
gens has also been emphasized by different authors
[48,91]. Further studies are needed to ascertain any poten-
tial impact of abnormal chromatin packaging on the
development of the resulting early embryo.
Epigenetic modifications
Histone modification
Histones are the best candidates for the transmission of
epigenetic information because of their influence on the
modification of chromatin structure, which modulates
access of the machinery to the genes in an organized pat-
tern [96,97]. Gene activity is determined by methylation,
acetylation, ubiquitylation and phosphorylation of his-
tones depending on the nature and position of modifica-
tion of the amino acid involved [98]. Histone acetylation
is associated with transcriptional activity, which is regu-
lated by the activity, concentration, interaction and avail-
ability of cofactors of histone acetyl transferases (HATs)
and histone deacetylases (HDACs).
Histone methylation is a complex process that confers a
high degree of specificity in the regulation of gene expres-
sion. In spermatogenesis, histone methylation is carried
out by the H3-K4 and H3-K9 methyltransferase families.
These methylatransferases facilitate gene silencing by
mono-, di- or trimethylation of lysine or arginine
[99,100]. The number and location of methyl groups on
the sperm-specific histones is one component of gene reg-
ulation in spermatogenesis. It has yet to be determined if
these modified histones play a crucial role in gene expres-
sion during early embryogenesis or whether abnormal
histone modifications in the sperm are associated with
diminished embryo development as well.
DNA methylation
DNA methylation is another major epigenetic factor that
regulates the function of the genome along with histone
modification. The methylation of DNA is catalyzed by
DNA methyltransferases, namely DNMT1, which restore
the DNA methylation pattern of CpG islands following
DNA replication. DNMT3a and DNMT3b are responsible
for establishing de novo DNA methylation. DNA methyl-
transferases transfer a methyl group to CpG dinucleotide
residues in order to regulate gene activity. Hypomethyla-
tion is associated with transcriptional activity while hyper-
methylation is associated with gene silencing through
methyl-CpG-binding proteins, which contain a transcrip-
tion repression domain [99,100].Journal of Experimental & Clinical Assisted Reproduction 2008, 5:2 http://www.jexpclinassistreprod.com/content/5/1/2
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During germ cell development the whole genome is
demethylated, which erases parental imprinting marks
and the newly establish methylation pattern results in the
resetting of imprints. The maternal and paternal DNA are
methylated in a parent-of-origin-dependent manner,
resulting in a different expression pattern of imprinted
genes between genders. Following fertilization, genome-
wide active demethylation of the paternal genome takes
place, then both the paternal and maternal genomes
undergo demethylation by a passive mechanism with the
exception of some regions such as imprinted genes, restor-
ing the totipotency to the fertilized egg. After implanta-
tion remethylation of the embryonic genome takes place,
establishing a hypermethylated ICM compare to the tro-
phoblast [100-104].
Alterations in methylation patterns can result in biallelic
expression or repression of imprinted genes and can cause
malformation [105]. More than half of the cases of Beck-
with-Wiedeman syndrome and around 10% of the cases
of Angelman syndrome are associated with epigenetic
defects. These syndromes appear to occur at a higher inci-
dence following ICSI [3-5]. A method for measuring the
global methylation status of sperm DNA by immunos-
taining of 5 methyl-cytosine was reported by Benchaib et
al. In their preliminary study, the DNA methylation level
was decreased in the sperm of patients with astheno-
zoospermia and teratozoospermia compared to that from
normal ejaculate [106]. In another study a correlation was
found between global mehylation level and pregnancy
rates [107]. No differences in the global DNA methylation
patterns were seen in protamine-deficient sperm samples
indicating that this assay might not sensitive enough to
detect variation in epigenetic modification [108]. More
informative techniques such as bisulfite genomic
sequencing or CpG island microarrays [99] should be
used to analyze methylation patterns of imprinted genes
rather than global DNA methylation to identify possible
differences in infertile males. Categorization of infertile
men by a more detailed analysis of DNA methylation pat-
tern might reveal a new origin of reduced fertilization,
implantation or pregnancy rates. However the application
of this technique in a clinical setting in the near future
cannot be expected.
RNA-associated silencing
Small noncoding RNAs (ncRNA) have recently been asso-
ciated with epigenetic modifications [109]. A suite of non-
coding RNAs, probably micro RNAs (miRNAs) and small
interfering RNAs (siRNAs) has been identified in human
sperm [110]. Recently another type of interfering RNA
called PIWI interacting RNAs (piRNAs) has been
described in mouse. These are longer than miRNAs or siR-
NAs and found to bind to PIWI [111]. Whether these non-
coding RNAs have an effect on embryogenesis and if so,
what their role is, are intriguing questions to answer in the
future.
mRNAs
It has long been thought that spermatozoa are transcrip-
tionally quiescent. Despite this, it was found that mature
spermatozoa contain fully processed mRNA, albeit in a
much lower amount compared to mature oocytes [111-
114]. First it was assumed that these mRNAs were leftover
from spermatogenesis, but there is evidence that the sper-
matozoa delivers a unique set of mRNAs to the oocyte at
fertilization that have been hypothesized to be necessary
for proper embryogenesis. Furthermore, the fact that
some of these spermatozoal mRNAs are also found in
zygotes indicates these transcripts may be functionally
important [115,116]. The spermatozoal mRNA finger-
print of individuals can be identified by microarray anal-
ysis. Any alteration in the amount or composition of
sperm mRNAs may indicate abnormalities in sperma-
togenesis [116]. It has been already shown that mRNA fin-
gerprint differs between normospermic and
teratozoospermic men [117]. This finding supports the
idea that perturbation in the transcription in late spermio-
genesis may affect embryogenesis. The correlation
between the sperm mRNA fingerprint and embryogenesis
needs further clarification in the future.
Conclusion
Since ICSI became a treatment option for many type of
severe male factor infertility including azoospermia, there
is a growing concern about the safety of the treatment. The
fertilizing spermatozoon is associated with more func-
tions than only providing half of the genetic material to
the oocyte. There are several factors that should be consid-
ered choosing the proper treatment option.
The integrity of the haploid set of chromosomes is highly
important. The recognition of genetic abnormalities such
as DNA fragmentation or sperm aneuploidy is already
possible, however the routine clinical application remains
limited. The characterization of patients who can benefit
from it is obvious in some cases however needs further
investigation. Using sperm for IVF treatment from these
patients can lead to reduced fertilization, diminished
implantation and pregnancy rates or production of aneu-
ploid offspring. Since ICSI has been extensively used to
treat many kinds of male infertility, there is higher risk for
propagating these heritable anomalies to the future gener-
ations.
Recently, the investigation of the contribution of the sper-
matozoa to early embryogenesis beyond the genetic fac-
tors has gained attention. There is evidence of epigenetic
contribution to complex diseases. Epigenetic factors men-
tioned above likely contribute to embryogenesis since it isJournal of Experimental & Clinical Assisted Reproduction 2008, 5:2 http://www.jexpclinassistreprod.com/content/5/1/2
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believed that the totipotency of the embryo is the result of
genome wide demethylation. DNA methylation and his-
tone modification are acting together. Abnormalities in
either or both functions might result to diminished ferti-
lization, disturbed embryogenesis or reduced implanta-
tion and pregnancy rates. Studies evaluating epigenetic
factors in relation to infertility or embryogenesis are in its
infants. More effort should be taken in order to study the
clinical aspects of epigenetic abnormalities.
More information is sorely needed to evaluate the risk of
transmission of genetic or epigenetic defects in order to
offer safer infertility treatments. The first step is the wider
application the existing knowledge by developing relia-
ble, cheap and easy to use assays for clinics. Extensive
research is ahead to developing more informative assays
in relation to identify paternal factors, as well as the mech-
anisms that they are involved in early embryogenesis.
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